191. Genetic Syndromes Flashcards

1
Q

Neuroendocrine tumor of the C-cells of the thyroid gland

All MEN 2 patients will develop __

  • MEN2A incidence peaks in 3rd decade of life
  • MEN2B occurs earlier and is more aggressive

75% of cases are sporadic, but will have __ mutation

Early thyroidectomy is important

A

MTC

RET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classic triad of symptoms with paragangliomas/pheochromocytomas

Half of patients will have paroxysmal hypertension as well

A
  1. Episodic headache
  2. Sweating
  3. Tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

AD syndrome with a two-hit model in a tumor suppressor gene

Clinical features:

  • hemangioblastomas of the brain
  • retinal capillary hemangioblastomas
  • clear cell renal carcinomas
  • pheochromocytomas
  • endolymphatic tumors of the middle ear
  • neuroendocrine tumors of the pancreas
  • papillary cystadenomas of the epididymis and broad ligament
A

Von Hippel-Lindau

Mutations in the VHL gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most common genotype is 45 XO, but may have a partial monosomy
- may be mosaic genotype

A

Turner Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

90-95% of cases

Medullary Thyroid cancer (90-100% of cases)
- presents later compared to its cohort

Primary Hyperparathyroidism (0-20%)

Pheochromocytomas (0-50%)

Extra-endocrine manifestations:

  • Hirschsprung’s disease
  • Cutaneous lichen amyloidosis
A

MEN2A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Genetic defect causing abnormal insulin secretion and a low renal threshold for glucose
- defect in hepatocyte nuclear factor-1-alpha

Risk of microvascular disease

Treated with sulfonylureas

A

Type 3 MODY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Designates the fact that an identical or highly similar phenotype may result from mutations in different genes

A

Locus heterogeneity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Presents as:

  • increased length of the arms and legs
  • gynecomastia
  • psychosocial abnormality
  • inattention
  • impairment of linguistic function
  • small, firm testes with low sperm count and infertility = hypogonadism

Higher risk of insulin resistance and Type 2 DM

A

Klinefelter’s Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Classic virilizing CAH in __:

- ambiguous genitalia at birth due to excess androgens in utero

A

Females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Catecholamine-producing tumor in the adrenal medulla

A

Pheochromocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Germline mutation in TK2 (intracellular domain) of RET proto-oncogene leads to

A

MEN2B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In monozygotic twins where on twin has type 2 DM, there is __% chance the other twin develops type 2 DM

A

90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Most common types of MODY? (2 of them)

A

Type 2 and Type 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hyperfunctioning endocrinopathies 2/2 to disease:

  • gonadotropin-independent precocious puberty
  • hyperthyroidism
  • GH excess
  • hyperprolactinemia
  • hypercorticolism

Non-endocrine manifestations:

  • heart disease
  • renal phosphate wasting
  • hepatobiliary dysfunction
A

McCune-Albright Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MEN
Von Hippel Lindau
Li Fraumeni
Pheochromocytoma/Paraganglioma Syndromes

A

Endocrine Tumor Syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indicates that different mutations in the same gene can cause an identical or similar phenotype

A

Allelic heterogeneity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Most __ are lethal during early fetal development

A

Monosomies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Most common pancreatic/duodenal tumor of MEN1
- also found in Zollinger-Ellison Syndrome

Also, other tumors seen in this region are

  • insulinomas
  • non-functioning tumors
  • carcinoid/VIPomas/glucagonomas
A

Gastrinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Genetic defect in glucokinase which alters cells’ abilities to sense glucose
- increased plasma levels of glucose

No risk of microvascular disease typically

Treat w/ diet modification

A

Type 2 MODY

20
Q

MEN2 is an AD gain of function mutation of __ proto-oncogene

21
Q

AD

Classic manifestations = 3 Ps

  • parathyroid
  • pancreas
  • pituitary
22
Q

Autoimmune Polyglandular Syndromes are d/t mutation in the __ gene
- modulates the transcription of peripheral self-antigens in the thymus rpesented by HLA molecules to maturing T cells

APS1, APS2, APS3, APS4
- associated with other autoimmune diseases

23
Q

5-10% of cases

Medullary Thyroid Carcinoma (100%)
- presents earlier and tends to be more aggressive compared to its cohort

Pheochromocytoma

Intestinal ganglioneuromas

Specific Phenotype

24
Q

Classic virilizing CAH in __:
- Age 1-4 weeks suffers from adrenal insufficiency with failure to thrive, vomiting, dehydration, hypotension, hyponatremia, hyperkalemia, shock

25
Single gene defect leading to the development of DM - AD mode of transmission Often misdiagnosed as type 2 DM - lack of diabetes autoantibodies (so not type 1 either)
Monogenic Diabetes (MODY)
26
Presents as: - Small ovaries with few or no follicles, STREAK GONADS leading to infertility - short stature - swelling of hands and feet - shield chest - webbed neck - low set hairline - heart disease - coarctation of aorta - horseshoe kidney - ear infections and hearing loss - ADHD - non-verbal learning disability Higher risk of autoimmune conditions Require estrogen-replacement therapy
Turner Syndrome
27
What do you treat classic virilizing CAH with?
Hydrocortisone and salt supplementation
28
AD inactivation of PRKAR1A Endocrine manifestations: - adrenocortical tumors - primary pigmented nodular adrenocortical disease leads to Cushing's Syndrome - thyroid nodules - pituitary adenomas - large cell calcifying sertoli cell tumor of the testicles - ovarian cysts or teratomas Non-endocrine manifestations: - Skin: cafe au lait spots, myxomas, blue nevi, lentigines - Eyes: pigmented lesions of conjunctiva and palpebra - cardiac myxomas - nerve sheath tumors - breast myxomas - osteochrondromyxoma - rarely: uterine myxoma, hepatocellular myxoma, pancreatic neoplasms
Carney complex
29
Extraadrenal tumor on sympathetic or parasympathetic ganglia - can be secretory (abdominal) or non-functional (head and neck)
Paraganglioma
30
Most common manifestation of MEN 1 - presents in 2nd-4th decade of life - generally needs treatment with 3.5 gland resection
Primary hyperparathyroidism
31
Mutated protein in MEN1 Undergoes "two hit" hypothesis
Menin
32
AD mutation in the tumor protein p53 - damaged DNA can survive and proliferate Clinical manifestations: - sarcoma - premenopausal breast cancer - brain tumors: gliomas and medulloblastoma - adrenocortical tumors
Li Fraumeni Syndrome
33
Marfinoid Habitus with scoliosis High-arched palate Megacolon Neuromas on tongue, mouth, and eyelid
MEN2B (specific phenotype)
34
__ mutations that lead to disease are more likely to manifest in adulthood, unlike chromosomal and monogenic diseases that appear after birth-prepuberty
Polygenic
35
Germline mutation (intracellular and extracellular) of RET proto-oncogene leads to
Familial MTC
36
Most common cause of male hypogonadism (1:1000 males in US) Most common genotype is 47 XXY - due to non-disjunction of sex chromosomes - Can be mosaic
Klinefelter's Syndrome
37
Examines the protein instead of the gene | - ex: looking for adrenal intermediates for CAH
Biochemical testing
38
Most common pituitary adenoma of MEN1
Prolactinoma
39
Helps us to understand the link between genetic variation and response to medications More studies needed in the field of Type 2 DM as it may be possible to optimize and individualize treatment plans
Pharmacogenetics
40
Lifetime risk for a first degree relative is __-__ times higher than age and weight matched controls without a first degree relative with type 2 DM
5-10
41
Accounts for 90% of CAH cases Genetics: - chromosome 6p21 - allows recombination during meiosis - everyone has 2 genes, the active and non-functional pseudogene are 90% homologous - unequal crossover events where large deletions or pseudodeleterious material can cross from non-function pseudogene to active form
21 Hydroxylase Deficiency
42
Examination of chromosomes to identify structural abnormalities - translocations, monosomy, trisomy
Cytogenic testing
43
Group of AR disorders which causes a deficiency of an enzyme involved in both the synthesis of cortisol, aldosterone, or both 67% are "salt losing" - salt wasting 33% are "simple virilizing" Higher mutation rates in Ashkenazi Jews and Yupik in Alaska
CAH
44
Clinical features: - Cafe au lait spots - neurofibromas - axillary and inguinal freckling - optic pathway gliomas (may lead to gigantism d/t GH secretion) - lisch nodules of the iris Endocrine tumors: - pheo - paragangliomas - GI tract/pancreatic tumors
NF1
45
Postzygotic (mosaic) activating mutation of the alpha subunit of the stimulatory Gs protein Triad: - cafe au lait spots - fibrous dysplasia of the bone - precocious puberty
McCune-Albright Syndrome
46
Germline mutation in the extracellular domain of RET proto-oncogene leads to (2 conditions)
MEN2A | Familial MTC
47
Neurofibromatosis 1 is an AD mutation in tumor suppressor gene NF1 It expresses __ penetrance and __ expressivity - patients with same genotype, may have different clinical symptoms
Complete | Variable